This is a preview of subscription content, log in via an institution to check access.
References
Costanzo MS, Hartl DL. The evolutionary landscape of antifolate resistance in Plasmodium falciparum. J Genet. 2011;90:187–90.
Dahl EL, Rosenthal PJ. Apicoplast translation, transcription and genome replication: targets for antimalarial antibiotics. Trends Parasitol. 2008;24:279–84.
Derrer B, Macheroux P, Kappes B. The shikimate pathway in apicomplexan parasites: implications for drug development. Front Biosci. 2013;18:944–69.
Gregson A, Plowe CV. Mechanisms of resistance of malaria parasites to antifolates. Pharmacol Rev. 2005;57:117–45.
Gutman J, Kachur SP, Slutsker L, Nzila A, Mutabingwa T. Combination of probenecid-sulphadoxine-pyrimethamine for intermittent preventive treatment in pregnancy. Malar J. 2012;11:39.
Hyde JE. Exploring the folate pathway in Plasmodium falciparum. Acta Trop. 2005a;94:191–206.
Hyde JE. Drug-resistant malaria. Trends Parasitol. 2005b;21:494–8.
Hyde JE. Targeting purine and pyrimidine metabolism in human apicomplexan parasites. Curr Drug Targ. 2007a;8:31–47.
Hyde JE. Drug-resistant malaria – an insight. FEBS J. 2007b;274:4688–98.
Hyde JE, Müller IB. Targeting folate metabolism in the human malaria parasite Plasmodium falciparum. Curr Enzym Inhib. 2012;8:150–69.
Hyde JE, Dittrich S, Wang P, Sims PFG, de Crécy-Lagard V, Hanson AD. Plasmodium falciparum: a paradigm for alternative folate biosynthesis in diverse microorganisms? Trends Parasitol. 2008;24:502–8.
Müller IB, Hyde JE. Antimalarial drugs: modes of action and mechanisms of parasite resistance. Future Microbiol. 2010;5:1857–75.
Müller IB, Hyde JE. Folate metabolism in human malaria parasites – 75 years on. Mol Biochem Parasitol. 2013;188:63–77.
Müller IB, Hyde JE, Wrenger C. Vitamin B metabolism in Plasmodium falciparum as a source of drug targets. Trends Parasitol. 2010;26:35–43.
Nzila A. The past, present and future of antifolates in the treatment of Plasmodium falciparum infection. J Antimicrob Chemother. 2006a;57:1043–54.
Nzila A. Inhibitors of de novo folate enzymes in Plasmodium falciparum. Drug Discov Today. 2006b;11:939–44.
Nzila A, Ward SA, Marsh K, Sims PFG, Hyde JE. Comparative folate metabolism in humans and malaria parasites (part II): activities as yet untargeted or specific to Plasmodium. Trends Parasitol. 2005a;21:334–9.
Nzila A, Ward SA, Marsh K, Sims PFG, Hyde JE. Comparative folate metabolism in humans and malaria parasites (part I): pointers for malaria treatment from cancer chemotherapy. Trends Parasitol. 2005b;21:292–8.
Salcedo E, Sims PFG, Hyde JE. A glycine-cleavage complex as part of the folate one-carbon metabolism of Plasmodium falciparum. Trends Parasitol. 2005;21:406–11.
Salcedo-Sora JE, Ward SA. The folate metabolic network of falciparum malaria. Mol Biochem Parasitol. 2013;188:51–62.
Yuthavong Y, Yuvaniyama J, Chitnumsub P, Vanichtanankul J, Chusacultanachai S, Tarnchompoo B, et al. Malarial (Plasmodium falciparum) dihydrofolate reductase-thymidylate synthase: structural basis for antifolate resistance and development of effective inhibitors. Parasitology. 2005;130:249–59.
Yuthavong Y, Kamchonwongpaisan S, Leartsakulpanich U, Chitnumsub P. Folate metabolism as a source of molecular targets for antimalarials. Future Microbiol. 2006;1:113–25.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this entry
Cite this entry
Hyde, J.E., Müller, I.B. (2013). Folate Metabolism. In: Hommel, M., Kremsner, P. (eds) Encyclopedia of Malaria. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-8757-9_1-1
Download citation
DOI: https://doi.org/10.1007/978-1-4614-8757-9_1-1
Received:
Accepted:
Published:
Publisher Name: Springer, New York, NY
Online ISBN: 978-1-4614-8757-9
eBook Packages: Springer Reference MedicineReference Module Medicine